SEC ownership of INTELLIGENT BIO SOLUTIONS INC.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001725430.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

Life Science Biosensor Diagnostics Pty Ltd

Comparable rows

3/23

Latest evidence

31 Mar 2026

Top shareholders Insider holders Latest transactions

Public ticker: INBS on Nasdaq
Parsed ownership sources: 13F, 13D/G, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
Largest SEC-reported holder: ARMISTICE CAPITAL, LLC
Ranking: Comparable ownership first, then disclosed value
Comparable ownership rows: 3 of 23
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder: ARMISTICE CAPITAL, LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date: 31 Mar 2026
Freshness: Most recent filing date in this holder set
Issuer CIK: 0001725430
Issuer location: New York, NY

Ownership snapshot

Top shareholders of INTELLIGENT BIO SOLUTIONS INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

Life Science Biosensor Di...

Comparable rows

3/23

Latest evidence

31 Mar 2026

13F 13D/G 3/4/5 Lead comparable stake: 10% 20 rows are not safely comparable across share classes. 13D/G row: ARMISTICE CAPITAL, LLC Showing 1-8 of 23 holder rows.

Quick read

ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 10%.

3 of 23 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.

Comparable ownership Top 3

ARMISTICE CAPITAL, LLC 10%

Alyeska Investment Group, L.P. 10%

BIGGER CAPITAL FUND L P 5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 23 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARMISTICE CAPITAL, LLC	13F 13D/G Company 13F 13D/G	10% from 13D/G	$434,850 130,000 shares	—	31 Mar 2026
Alyeska Investment Group, L.P.	13F 13D/G Company 13F 13D/G	10% from 13D/G	$126,963 37,956 shares	—	31 Mar 2026
BIGGER CAPITAL FUND L P	13D/G Bigger Michael 13D/G	5%	$50,000 303,032 shares	$0	31 Dec 2024
Life Science Biosensor Diagnostics Pty Ltd	3/4/5 Former 10% owner 3/4/5	— class O/S missing	$2,001,337 1,081,804 shares	—	17 Feb 2022
Ma-Ran Foundation	3/4/5 10%+ Owner 3/4/5	— class O/S missing	$394,540 213,265 shares	—	12 May 2023
Gary W. Rollins Foundation	3/4/5 10%+ Owner 3/4/5	— class O/S missing	$352,405 190,489 shares	—	12 May 2023
Spiro Kevin Sakiris	3/4/5 Chief Financial Officer 3/4/5	— class O/S missing	$140,337 35,892 shares	—	18 Mar 2026
Harry Simeonidis	3/4/5 Chief Executive Officer 3/4/5	— class O/S missing	$135,051 34,540 shares	—	18 Mar 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 03 Aug 2025.

Buys

Insiders: 0

Sells

Insiders: 0

Net

Shares: 0

Window

Last 12 months

4 rolling buckets

Buy value Sell value

Shares: 0 Shares: 0

Window (months)	Buy value	Sell value	Net value
0-3	$0	$0	$0
3-6	$0	$0	$0
6-9	$0	$0	$0
9-12	$0	$0	$0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-14 of 14 reporting-owner rows connected to INTELLIGENT BIO SOLUTIONS INC.. Open a relationship link for the CIK-to-CIK filing trail.

Rows

Largest Forms 3/4/5 holder

Life Science Biosensor Diagnostics Pty Ltd

Net 12M change

Latest report

18 Mar 2026

Name	Relationship	Holdings Value	Valuation	Report Date
Life Science Biosensor Diagnostics Pty Ltd	Former 10% owner	$2,001,337	Mixed	17 Feb 2022
Ma-Ran Foundation	10%+ Owner	$394,540	Mixed	12 May 2023
Gary W. Rollins Foundation	10%+ Owner	$352,405	Mixed	12 May 2023
Spiro Kevin Sakiris	Chief Financial Officer	$140,337	Mixed	18 Mar 2026
Harry Simeonidis	Chief Executive Officer	$135,051	Mixed	18 Mar 2026
George Margelis	Director	$27,750	Mixed	10 Oct 2022
Lawrence B. Fisher	Director	$27,750	Mixed	10 Oct 2022
Steven Constantine Boyages	Director	$19,671	Mixed	18 Mar 2026
Jonathan Scott Hurd	Director	$19,573	Mixed	18 Mar 2026
Jason Isenberg	Director	$19,550	Mixed	18 Mar 2026
Nicola Marion Fraser	Director	$19,550	Mixed	18 Mar 2026
Christopher Towers	Director	$18,278	Mixed	04 Oct 2023
Tom Parmakellis	Director	$17,205	Mixed	30 Dec 2021
David A. Jenkins	Director		Mixed	04 Oct 2022

Recent insider transactions for INTELLIGENT BIO SOLUTIONS INC.

Showing up to 300 recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Shares	Shares owned	Date	Ownership
Steven Constantine Boyages	INBS	Common Stock	Award	16129%	5,000	5,031	18 Mar 2026	Direct
Nicola Marion Fraser	INBS	Common Stock	Award		5,000	5,000	18 Mar 2026	Direct
Spiro Kevin Sakiris	INBS	Common Stock	Award	876.2%	30,500	33,981	18 Mar 2026	Direct
Jonathan Scott Hurd	INBS	Common Stock	Award	83333.3%	5,000	5,006	18 Mar 2026	Direct
Jason Isenberg	INBS	Common Stock	Award		5,000	5,000	18 Mar 2026	Direct
Harry Simeonidis	INBS	Common Stock	Award	755%	30,500	34,540	18 Mar 2026	Direct

^* marks a reported price that did not pass the local price check.